Fragile X Syndrome and Targeted Treatments
Many targeted treatment studies have been carried out in individuals with Fragile X Syndrome (FXS) guided by animal studies from the Fragile X Mental Retardation 1 (FMR1) knock out (KO) mice and the fragile X Drosophila studies. Here we review the many medications that have been studied in patients...
Guardado en:
Autores principales: | Nattaporn Tassanakijpanich, Ana María Cabal-Herrera, Maria Jimena Salcedo-Arellano, Randi Jenssen Hagerman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Diponegoro University
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e75efb3b52fc469bbf4c4b7a35bd2cbe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Maternal Mental Health and Parenting Stress and Their Relationships to Characteristics of the Child With Fragile X Syndrome
por: Lauren Bullard, et al.
Publicado: (2021) -
Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis
por: Scott Thomas, et al.
Publicado: (2021) -
The Use of Peptides in the Treatment of Fragile X Syndrome: Challenges and Opportunities
por: Alice Romagnoli, et al.
Publicado: (2021) -
Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in <i>FMR1</i> and Associated Phenotypes
por: Cedrik Tekendo-Ngongang, et al.
Publicado: (2021) -
Síndrome del X-Frágil: Discusión del Primer Caso confirmado citogenéticamente en Chile
por: Lacassle S,Yves, et al.
Publicado: (1983)